AbbVie (NYSE:ABBV) FY Conference Transcript

AbbVie (NYSE:ABBV) FY Conference September 09, 2025 10:00 AM ET Company ParticipantsRobert Michael - CEO & Chairman of BoardRoopal Thakkar - EVP - R&D & Chief Scientific OfficerJeffrey Stewart - EVP & CCOConference Call ParticipantsTerence Flynn - Equity Research AnalystTerence FlynnGreat. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting AbbVie this morning. Joining us from the company, we have the company CEO, Rob Michael. We have ...